JG King Homes and the Fiona Elsey Cancer Research Institute

Aug 10, 2022

JG King Homes & Fiona Elsey Cancer Research Institute partnership

JG King Homes are proud to have selected the Fiona Elsey Cancer Research Institute as their chosen corporate charity partner. The partnership includes an annual donation of $100,000 to help the institutes important research into finding a cure for cancer. When it came to choosing a partner, FECRI was the perfect choice as much like JG King Homes, the institute was conceived and still operates out of Ballarat.

JG King Homes director, John King said that his organisation valued the great relationship they have built within the local community. “We have seen first-hand the impact cancer has had on staff, suppliers, clients and their loved ones. We are pleased that that our donation into ground breaking medical research at The Fiona Elsey will play a critical role in advancing the search for cancer cures, treatments and better outcomes for patients.”

Pictured above after their first quarterly donation are John King (Managing Director), Professor George Kannourakis (FECRI), John King (Executive Director) and Angelo Tsagarakis (CEO).

About Fiona Elsey Cancer Research Institute

Each day 396 Australians will be diagnosed with cancer. Families and friends are shattered by the way a challenging illness affects their loved ones and each day people continue to die. Diagnosis and treatments are improving all the time. But while this disease kills, research for a cure is important.

The Fiona Elsey Cancer Research Institute (FECRI) is a world class cancer research facility based in Ballarat, in regional Victoria. As Australia’s only regionally based cancer research centre, it is community funded relying on fundraising and donations to continue research into more effective ways to diagnose and treat cancer.

Opened in 1998, the Institute was inspired by Ballarat teenager, Fiona Elsey who lost her fight with cancer in 1991. Today the Institute is making a world class contribution to cancer research, with recent recognition for achievements into Bowel cancer, triple negative Breast cancer, chemo resistance in ovarian cancer and in the understanding of histiocytic disorders.

Key projects being conducted at the Institute are:

• Ovarian cancer

• Breast cancer

• Immunology

• Chronic lymphocytic leukaemia

• Renal cancer

• Bowel cancer

• Liver cancer

• Langerhans cell histiocytosis

To find out more about the institute you can visit their website and to donate click here